TP53 and lung carcinoma: Detection of a panel of autoantibodies against seven various targets (p53, GAGE7, PGP9.5, CAGE, MAGEA1, SOX2 and GBU4-5) was suggested to have significant clinical value for early diagnosis of lung cancer (146).